Topic: healthcare

The experimental lung cancer drug ivonescimab from Akeso and Summit Therapeutics has shown a 34% reduction in the risk of death in a late-stage trial, which could position it as a significant player in the oncology market, particularly for squamous non-small-cell lung cancer patients.

Morgan Stanley identifies several companies that could significantly enhance investor returns by initiating dividend payments, highlighting their potential for outsized performance in the market.

Several companies reported earnings and guidance updates after hours, with notable movements in their stock prices reflecting investor reactions to the news. Salesforce, Agilent Technologies, and Snowflake stood out with positive earnings surprises and raised guidance, while others like Everpure and American Superconductor faced declines despite beating revenue expectations.